The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Hoenigl, Martin; Seidel, Danila; Carvalho, Agostinho; M Rudramurthy, Shivaprakash; Arastehfar, Amir; Gangneux, Jean-Pierre; Nasir, Nosheen; Bonifaz, Alexandro; Araiza, Javier; Klimko, Nikolai; Serris, Alexandra; Lagrou, Katrien; F Meis, Jacques; A Cornely, Oliver; R Perfect, John; Lewis White, P; Chakrabarti, Arunaloke

doi:10.1016/s2666-5247(21)00237-8

Public

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Published in The Lancet Microbe • Jan 25, 2022

Authors:

Martin Hoenigl

Danila Seidel

Agostinho Carvalho

Abstract

Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS...

Subject

Mucormycosis

Medicine

Diabetes mellitus

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!